Cargando…
O033 Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome
BACKGROUND: Autonomic dysfunction has been implicated in the pathophysiology of Sudden Infant Death Syndrome (SIDS). Butyrylcholinesterase (BChE) is an enzyme of the cholinergic system, a major branch of the autonomic system, and may provide a measure of autonomic (dys)function. This study was under...
Autores principales: | Harrington, C, Al Hafid, N, Waters, K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109202/ http://dx.doi.org/10.1093/sleepadvances/zpac029.032 |
Ejemplares similares
-
Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome
por: Harrington, Carmel Therese, et al.
Publicado: (2022) -
Letter Re: Butyrylcholinesterase is a potential biomarker for sudden infant death syndrome
por: Harrington, Carmel Therese, et al.
Publicado: (2022) -
Letter to Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome
por: Durner, Jürgen
Publicado: (2022) -
O033 Is Sleeping and Waking Important for the Cortisol Awakening Response?
por: Grosser, L, et al.
Publicado: (2023) -
O033. TDCs treatment: long term results in drug resistant migrainous patients
por: Dalla Volta, Giorgio, et al.
Publicado: (2015)